Bisimide compounds
    7.
    发明授权
    Bisimide compounds 失效
    双酰亚胺化合物

    公开(公告)号:US5854273A

    公开(公告)日:1998-12-29

    申请号:US899289

    申请日:1997-07-23

    CPC分类号: C07D209/80 C09B57/08

    摘要: A compound of formula (I) ##STR1## in which: X and Y, which may be identical or different, represent hydrogen or halogen or alkyl, trihaloalkyl, alkoxy, hydroxyl, cyano, nitro, amino, alkylamino, or dialkylamino, Z represent a linear or branched C.sub.4 to C.sub.12 alkylene chain in which one or more --CH.sub.2 -- are optionally replaced by any one of the following atoms or groups: --NR--, --O--, --S--, --SO--, --SO.sub.2 --, or --CONH--, A forms, with two adjacent carbon atoms of the phenyl ring, a phenyl, naphthyl or tetrahydronaphthyl ring or a heterocycle, ##STR2## represents any one of the groups as defined in the description, its optical isomers and its addition salts with a pharmaceutically-acceptable acid or base, and medicinal products containing the same which are useful as anticancer agents.

    摘要翻译: 式(I)化合物其中:X和Y可以相同或不同,表示氢或卤素或烷基,三卤代烷基,烷氧基,羟基,氰基,硝基,氨基,烷基氨基或二烷基氨基 Z表示直链或支链的C 4至C 12亚烷基链,其中一个或多个-CH 2 - 任选被以下原子或基团中的任何一个取代:-NR - , - O - , - S - , - SO-, - SO 2 - 或-CONH-,A形式,其具有苯环的两个相邻碳原子,苯基,萘基或四氢萘基环或杂环,IMAGE表示说明书中定义的任何一个基团,其旋光异构体 及其与药学上可接受的酸或碱的加成盐,以及含有该盐的药物,可用作抗癌剂。

    Dihydrofuro[3,4-b]quinolin-1-one compounds
    8.
    发明授权
    Dihydrofuro[3,4-b]quinolin-1-one compounds 失效
    二氢呋喃并[3,4-b]喹啉-1-酮化合物

    公开(公告)号:US06548515B1

    公开(公告)日:2003-04-15

    申请号:US09718917

    申请日:2000-11-22

    IPC分类号: A61K314741

    摘要: The invention relates to compound of formula (I): wherein: represents a single or double bond, R0 represents hydrogen or hydroxy or alkoxy, R1 and R2, which are identical or different, each represents hydrogen or halogen or alkyl, alkoxy, hydroxy, polyhaloalkyl, nitro or optionally substituted amino or  wherein m represents an integer such that 1≦m≦4, or form together with the carbon atoms carrying them an aromatic or non-aromatic, mono- or bi-cyclic group having from 5 to 12 ring members and optionally containing 1 or 2 hetero atoms selected from O, S and N, R3 represents hydrogen or aryl, heteroaryl, cycloalkyl, optionally substituted alkyl or a group of formula COR7 wherein R7 represents aryl, optionally substituted alkyl, optionally substituted amino or OR10 wherein R10 represents aryl or optionally substituted alkyl, X represents oxygen or sulphur or —CH2— or —CH2—CH2—, Ar represents aryl, heteroaryl or arylalkyl, its optical isomers, its hydrates, solvates, and also its addition salts with a pharmaceutically acceptable acid. Medicinal products containing the same are useful in the treatment of cancer.

    摘要翻译: 本发明涉及式(I)的化合物:其中:表示单键或双键,R 0表示氢或羟基或烷氧基,R 1和R 2相同或不同,各自表示氢或卤素或烷基,烷氧基,羟基,多卤代烷基,硝基或任选取代的氨基或 其中m表示1≤= m = 4的整数,或与带有带有5至12个环成员的芳族或非芳族单环或双环基团的碳原子一起形成,并且任选地含有1或 2个选自O,S和N的杂原子,R 3表示氢或芳基,杂芳基,环烷基,任选取代的烷基或式COR7基团,其中R7表示芳基,任选取代的烷基,任选取代的氨基或OR 10,其中R 10表示芳基或任选地 取代的烷基,X表示氧或硫或-CH 2 - 或-CH 2-CH 2 - ,Ar表示芳基,杂芳基或芳基烷基,其光学异构体,其水合物,溶剂合物,以及其与药学上可接受的酸的加成盐。含有它们的医药产品可用于治疗癌症。